Sex and Gender Differences in Pharmacology [electronic resource] /edited by Vera Regitz-Zagrosek.
by Regitz-Zagrosek, Vera [editor.]; SpringerLink (Online service).
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
MAIN LIBRARY | RM1-950 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
P98-98.5 The Czech Language in the Digital Age | QA319-329.9 Variational, Topological, and Partial Order Methods with Their Applications | TK1-9971 Interference Cancellation Using Space-Time Processing and Precoding Design | RM1-950 Sex and Gender Differences in Pharmacology | QA402.5-402.6 Bases, outils et principes pour l'analyse variationnelle | QA8.9-QA10.3 Correct Reasoning | HD9696.2-9696.82 Software Business |
From the contents -- Preface -- Part 1: Sex differences in mechanisms of disease -- Part 2: Sex differences in pharmacokinetics, in drug development and use -- Part 3: Sex differences in different therapeutic areas.
This is the very first book to deal with sex and gender differences in drug therapy - an increasingly recognized medical need. It starts with an overview on S/G in clinical syndromes and a documentation of the medical and socioeconomic damage caused by gender specific adverse drug effects. Part I covers S/G differences in pharmacokinetics. Researchers will be satisfied by the detailed discussion of the mechanisms of S/G differences in drug effects that represents cutting edge science and includes interaction of drugs with sex hormones, genomic and epigenetic mechanisms. It also covers S/G in drug development, in animal models and clinical development and S/G in drug prescriptions. Part II targets S/G differences in drug effects in cardiovascular, pulmonary, CNS, neuromuscular, neuropsychiatric and metabolic diseases, in cancer, inflammation, and rheumatic diseases, in bacterial and retroviral infections, thrombosis, embolism. New drugs will be discussed.
There are no comments for this item.